Quality of Drug Clinical Trials in China: A Mixed Methods Research
The quality of drug clinical trials in China has significantly improved over the past decade, yet there remains scope for further enhancement.
Authors
- Hongling Chu (ORCID: https://orcid.org/0000-0003-1846-9192)
- Jing Meng (ORCID: https://orcid.org/0000-0001-8708-0485)
- Yangfeng Wu (ORCID: https://orcid.org/0000-0002-4451-1932)
- Xiayan Chen (ORCID: https://orcid.org/0000-0002-0314-8102)
- Huijuan Li (ORCID: https://orcid.org/0000-0002-7758-824X)
- Xiaofang Zhang (ORCID: https://orcid.org/0000-0001-7184-1526)
Institutions
- Peking University (CN)
- Peking University First Hospital (CN)
- Peking University Third Hospital (CN)
Publication Details
- Journal
- Journal of Evidence-Based Medicine
- Published
- 2025-11-07
- DOI
- https://doi.org/10.1111/jebm.70085
- Citations
- 1
- Primary Topic
- Statistical Methods in Clinical Trials
- Type
- article
- Field-Weighted Citation Impact
- 2.63
Funders
- U.S. Food and Drug Administration